Search for: "Johnson v. Eli Lilly and Co."
Results 41 - 60
of 71
Sort by Relevance
|
Sort by Date
24 Feb 2011, 1:49 pm
Merrell Co., 174 So.2d 736, 738-39 (Fla. 1965); Estate of Johnson v. [read post]
3 Feb 2011, 2:11 pm
Bristol-Myers Squibb Co., 121 F. [read post]
26 Jan 2011, 10:04 am
Eli Lilly & Co., 598 F.3d 1336, 1347 (Fed. [read post]
20 Jan 2011, 4:50 pm
Cir. 2009); Liebel-Flarsheim Co. v. [read post]
29 Dec 2010, 12:54 pm
Eli Lilly & Co., 620 F.3d 121 (2d Cir. 2010). [read post]
6 Oct 2010, 7:46 am
Eli Lilly and Co., 2010 WL 3892464, at *1 (S.D. [read post]
2 Jul 2010, 5:00 pm
Supp.; Johnson v. [read post]
24 Jun 2010, 5:00 am
Eli Lilly & Co., 84 F.R.D. 230 (D.S.C. [read post]
21 May 2010, 8:58 am
Eli Lilly &Co. fell short of that requirement. [read post]
18 Feb 2010, 10:34 am
Because those are federal statutes, they can’t be “preempted” the way state-law claims were in Buckman Co. v. [read post]
3 Dec 2009, 12:13 am
Federal Judge Knocks Out Most of Mississippi's Zyprexa Case Against Eli Lilly The American Lawyer Mississippi Attorney General Jim Hood's aggressive posture against Eli Lilly in a case involving the controversial anti-psychotic Zyprexa hasn't paid off. [read post]
25 Jun 2009, 4:29 am
Eli Lilly & Co., 536 F.Supp.2d 767, 781 (S.D. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad… [read post]
23 Dec 2008, 1:00 pm
Eli Lilly & Co., 577 F. [read post]
18 Dec 2008, 10:36 pm
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983)). [read post]
6 Oct 2008, 5:00 am
Eli Lilly & Co., No. [read post]
26 Sep 2008, 10:19 am
Maryland's top court recently affirmed summary judgment for defendant Eli Lilly & Co., in a case brought by a widow whose husband was killed in an auto accident. [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]